Related references
Note: Only part of the references are listed.Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Drug Evaluation during the Covid-19 Pandemic
Benjamin N. Rome et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Retrospectively patient-reported pre-event health status showed strong association and agreement with contemporaneous reports
Esther Kwong et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)